Literature DB >> 27744369

Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.

Shobini Jayaraman1, Christian Haupt2, Olga Gursky1.   

Abstract

Oxidative stress and inflammation, which involve a dramatic increase in serum amyloid A (SAA) levels, are critical in the development of atherosclerosis. Most SAA circulates on plasma HDL particles, altering their cardioprotective properties. SAA-enriched HDL has diminished anti-oxidant effects on LDL, which may contribute to atherogenesis. We determined combined effects of SAA enrichment and oxidation on biochemical changes in HDL. Normal human HDLs were incubated with SAA, oxidized by various factors (Cu2+, myeloperoxidase, H2O2, OCl-), and analyzed for lipid and protein modifications and biophysical remodeling. Three novel findings are reported: addition of SAA reduces oxidation of HDL and LDL lipids; oxidation of SAA-containing HDL in the presence of OCl- generates a covalent heterodimer of SAA and apoA-I that resists the release from HDL; and mild oxidation promotes spontaneous release of proteins (SAA and apoA-I) from SAA-enriched HDL. We show that the anti-oxidant effects of SAA extend to various oxidants and are mediated mainly by the unbound protein. We propose that free SAA sequesters lipid hydroperoxides and delays lipoprotein oxidation, though much less efficiently than other anti-oxidant proteins, such as apoA-I, that SAA displaces from HDL. These findings prompt us to reconsider the role of SAA in lipid oxidation in vivo.
Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  amyloid A and apolipoprotein A-I amyloidosis; apolipoprotein release; high density lipoprotein; inflammation and atherosclerosis; lipoprotein peroxidation kinetics; low density lipoprotein; serum amyloid A

Mesh:

Substances:

Year:  2016        PMID: 27744369      PMCID: PMC5321215          DOI: 10.1194/jlr.M071191

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  61 in total

1.  Modification of low density lipoproteins by sodium hypochlorite.

Authors:  J Arnhold; D Wiegel; O Richter; S Hammerschmidt; K Arnold; M Krumbiegel
Journal:  Biomed Biochim Acta       Date:  1991

2.  Heparin interactions with apoA1 and SAA in inflammation-associated HDL.

Authors:  Andreas Digre; Jie Nan; Martin Frank; Jin-Ping Li
Journal:  Biochem Biophys Res Commun       Date:  2016-04-20       Impact factor: 3.575

Review 3.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.

Authors:  Shobini Jayaraman; Christian Haupt; Olga Gursky
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

5.  Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.

Authors:  Joseph A DiDonato; Kulwant Aulak; Ying Huang; Matthew Wagner; Gary Gerstenecker; Celalettin Topbas; Valentin Gogonea; Anthony J DiDonato; W H Wilson Tang; Ryan A Mehl; Paul L Fox; Edward F Plow; Jonathan D Smith; Edward A Fisher; Stanley L Hazen
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

Review 6.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

Review 7.  Serum amyloid A (SAA): an acute phase protein and apolipoprotein.

Authors:  E Malle; A Steinmetz; J G Raynes
Journal:  Atherosclerosis       Date:  1993-09       Impact factor: 5.162

8.  Mild oxidation promotes and advanced oxidation impairs remodeling of human high-density lipoprotein in vitro.

Authors:  Xuan Gao; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

Review 9.  Aggregation and fusion of low-density lipoproteins in vivo and in vitro.

Authors:  Mengxiao Lu; Olga Gursky
Journal:  Biomol Concepts       Date:  2013-10

10.  Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Authors:  A D Watson; M Navab; S Y Hama; A Sevanian; S M Prescott; D M Stafforini; T M McIntyre; B N Du; A M Fogelman; J A Berliner
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  11 in total

Review 1.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

2.  Structural Basis for Lipid Binding and Function by an Evolutionarily Conserved Protein, Serum Amyloid A.

Authors:  Nicholas M Frame; Meera Kumanan; Thomas E Wales; Asanga Bandara; Marcus Fändrich; John E Straub; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2020-02-06       Impact factor: 5.469

3.  Serum Amyloid A Is an Exchangeable Apolipoprotein.

Authors:  Patricia G Wilson; Joel C Thompson; Preetha Shridas; Patrick J McNamara; Maria C de Beer; Frederick C de Beer; Nancy R Webb; Lisa R Tannock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

Review 4.  Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.

Authors:  Fernando Brites; Maximiliano Martin; Isabelle Guillas; Anatol Kontush
Journal:  BBA Clin       Date:  2017-08-19

5.  Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3.

Authors:  Kayleigh Griffiths; Agnieszka Pazderska; Mohammed Ahmed; Anne McGowan; Alexander P Maxwell; Jane McEneny; James Gibney; Gareth J McKay
Journal:  J Diabetes Res       Date:  2017-05-09       Impact factor: 4.011

6.  HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.

Authors:  Kathrin Untersteller; Sabine Meissl; Markus Trieb; Insa E Emrich; Adam M Zawada; Michael Holzer; Eva Knuplez; Danilo Fliser; Gunnar H Heine; Gunther Marsche
Journal:  J Lipid Res       Date:  2018-05-22       Impact factor: 5.922

7.  Synergy between serum amyloid A and secretory phospholipase A2.

Authors:  Shobini Jayaraman; Marcus Fändrich; Olga Gursky
Journal:  Elife       Date:  2019-05-21       Impact factor: 8.140

Review 8.  High-Density Lipoproteins and Serum Amyloid A (SAA).

Authors:  Nancy R Webb
Journal:  Curr Atheroscler Rep       Date:  2021-01-15       Impact factor: 5.113

9.  Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial.

Authors:  Oluremi N Ajala; Olga V Demler; Yanyan Liu; Zareen Farukhi; Steven J Adelman; Heidi L Collins; Paul M Ridker; Daniel J Rader; Robert J Glynn; Samia Mora
Journal:  J Am Heart Assoc       Date:  2020-08-15       Impact factor: 5.501

Review 10.  Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.

Authors:  Olga Gursky
Journal:  Curr Atheroscler Rep       Date:  2020-09-24       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.